146 related articles for article (PubMed ID: 38118219)
1. Role of Wiskott Aldrich syndrome protein in haematological malignancies: genetics, molecular mechanisms and therapeutic strategies.
R P; Shanmugam G; Rakshit S; Sarkar K
Pathol Res Pract; 2024 Jan; 253():155026. PubMed ID: 38118219
[TBL] [Abstract][Full Text] [Related]
2. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
Blundell MP; Worth A; Bouma G; Thrasher AJ
Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
[TBL] [Abstract][Full Text] [Related]
3. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
[TBL] [Abstract][Full Text] [Related]
4. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding.
Massaad MJ; Ramesh N; Le Bras S; Giliani S; Notarangelo LD; Al-Herz W; Notarangelo LD; Geha RS
J Allergy Clin Immunol; 2011 Apr; 127(4):998-1005.e1-2. PubMed ID: 21376381
[TBL] [Abstract][Full Text] [Related]
5. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Boztug K; Dewey RA; Klein C
Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
[TBL] [Abstract][Full Text] [Related]
6. The Wiskott-Aldrich syndrome.
Ochs HD; Thrasher AJ
J Allergy Clin Immunol; 2006 Apr; 117(4):725-38; quiz 739. PubMed ID: 16630926
[TBL] [Abstract][Full Text] [Related]
7. The open conformation of WASP regulates its nuclear localization and gene transcription in myeloid cells.
Looi CY; Sasahara Y; Watanabe Y; Satoh M; Hakozaki I; Uchiyama M; Wong WF; Du W; Uchiyama T; Kumaki S; Tsuchiya S; Kure S
Int Immunol; 2014 Jun; 26(6):341-52. PubMed ID: 24402308
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
Ochs HD
Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
[TBL] [Abstract][Full Text] [Related]
9. Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation.
Notarangelo LD; Ochs HD
Curr Opin Immunol; 2003 Oct; 15(5):585-91. PubMed ID: 14499269
[TBL] [Abstract][Full Text] [Related]
10. The chemotactic defect in wiskott-Aldrich syndrome macrophages is due to the reduced persistence of directional protrusions.
Ishihara D; Dovas A; Park H; Isaac BM; Cox D
PLoS One; 2012; 7(1):e30033. PubMed ID: 22279563
[TBL] [Abstract][Full Text] [Related]
11. FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome.
Wang C; Sample KM; Gajendran B; Kapranov P; Liu W; Hu A; Zacksenhaus E; Li Y; Hao X; Ben-David Y
Front Immunol; 2021; 12():607836. PubMed ID: 33717090
[TBL] [Abstract][Full Text] [Related]
12. WIP remodeling actin behind the scenes: how WIP reshapes immune and other functions.
Noy E; Fried S; Matalon O; Barda-Saad M
Int J Mol Sci; 2012; 13(6):7629-7647. PubMed ID: 22837718
[TBL] [Abstract][Full Text] [Related]
13. WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome.
Sasahara Y
Pediatr Int; 2016 Jan; 58(1):4-7. PubMed ID: 26331277
[TBL] [Abstract][Full Text] [Related]
14. Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.
Prete F; Catucci M; Labrada M; Gobessi S; Castiello MC; Bonomi E; Aiuti A; Vermi W; Cancrini C; Metin A; Hambleton S; Bredius R; Notarangelo LD; van der Burg M; Kalinke U; Villa A; Benvenuti F
J Exp Med; 2013 Feb; 210(2):355-74. PubMed ID: 23337808
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
16. New insights into the biology of Wiskott-Aldrich syndrome (WAS).
Thrasher AJ
Hematology Am Soc Hematol Educ Program; 2009; ():132-8. PubMed ID: 20008191
[TBL] [Abstract][Full Text] [Related]
17. WASP and the phenotypic range associated with deficiency.
Notarangelo LD; Notarangelo LD; Ochs HD
Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):485-90. PubMed ID: 16264326
[TBL] [Abstract][Full Text] [Related]
18. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.
Liu DW; Zhang ZY; Zhao Q; Jiang LP; Liu W; Tu WW; Song WX; Zhao XD
Pediatr Blood Cancer; 2015 Sep; 62(9):1601-8. PubMed ID: 25931402
[TBL] [Abstract][Full Text] [Related]
19. [Molecular pathogenesis of Wiskott-Aldrich syndrome].
Sasahara Y; Tsuchiya S
Nihon Rinsho Meneki Gakkai Kaishi; 2005 Jun; 28(3):140-7. PubMed ID: 15997177
[TBL] [Abstract][Full Text] [Related]
20. Use of zinc-finger nucleases to knock out the WAS gene in K562 cells: a human cellular model for Wiskott-Aldrich syndrome.
Toscano MG; Anderson P; Muñoz P; Lucena G; Cobo M; Benabdellah K; Gregory PD; Holmes MC; Martin F
Dis Model Mech; 2013 Mar; 6(2):544-54. PubMed ID: 23324327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
